Ambrose Healthcare Ltd (Ambrose Healthcare), a specialist pharmaceutical company in rare diseases and hospital care, has won National Life Sciences Start-Up of the Year at the annual MediWales Innovation Awards.
The award recognizes Ambrose’s innovative approach to accelerating drug development and supply for the 94% of rare diseases without an approved treatment[1]. It’s estimated there are more than 10,000 rare diseases, affecting about 400 million people worldwide.[2,3]
Ambrose is building an axis of innovation from its Welsh headquarters to the United States and the Middle East through collaborations and new technology, including artificial intelligence.
Toby Wilson Waterworth, Chair and Chief Executive of Ambrose Healthcare, said: “We’re honored to win this year’s MediWales Innovation Award on behalf of the rare disease community. Our expertise in clinical development, combined with the latest technologies, offers new hope for more treatment options for millions of patients around the world.”
About Ambrose Healthcare Limited
Ambrose Healthcare is a specialist pharmaceutical company, developing new treatments for rare diseases and patients managed in hospitals and specialist care.
The company has an experienced leadership team with deep knowledge of the pharmaceutical industry and a track record of success, supported by an international network of rare disease experts and organizations.
Ambrose Healthcare is focused on acquiring late-stage drug assets with a minimum of Phase 2 data and that have novel applications in rare diseases.
Ambrose Healthcare is working towards becoming a centre of excellence and a premier rare disease company. Read more on the company’s approach in its recently published white paper.
About the MediWales Innovation Awards
The 18th annual MediWales Innovation Awards recognize the best of industry and health with a footprint in Wales.
Award categories for industry include Innovation, Start-up, Partnership with the NHS, Export and Outstanding Achievement.
Health awards include NHS Wales working with Industry, Technology & Digital Impact, Scaling up Innovation & Transformation, Social Care Innovation through Collaboration; and Health and Social Care Research Partnership with Industry.
For further information, visit: www.mediwales.com/event/mediwales-innovation-awards-2023/
References
1. New Study Investigates the Number of Available Orphan Products, Generics and Biosimilars (2021) National Organization for Rare Disorders. Available at: https://rarediseases.org/new-study-investigates-the-number-of-available-orphan-products-generics-and-biosimilars/ (Accessed: 7 December 2023).
2. Haendel et al (2020) How many rare diseases are there? Nat Rev Drug Discov. 19(2) 77-78
3. Introducing the Rare Diseases Genomics and Precision Health Knowledge Base (2019) Centers for Disease Control and Prevention. Available at: https://blogs.cdc.gov/genomics/2019/04/04/introducing-the-rare-diseases/ (Accessed: 7 December 2023).
For more information, please contact:
Adam Michael, Director of Communications
adam.michael@ambrosehc.com +44 7775 881 813